Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Colombo

Showing results (151-160 of 169) with videos related to

Pageof 17
Sort By:
Open Forum Infectious Diseases|July 28, 2022
An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 InfectionAnn I Scher, Catherine M Berjohn, Celia Byrne, et al.
Open Forum Infectious Diseases|December 13, 2021
Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019Stephanie A Richard, Nusrat J Epsi, Simon Pollett, et al.
Scientific Reports|December 28, 2022
Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19Paul W Blair, Joost Brandsma, Josh Chenoweth, et al.
Open Forum Infectious Diseases|February 10, 2022
Anatomical Site, Viral Ribonucleic Acid Abundance, and Time of Sampling Correlate With Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 During InfectionF Julian Lantry, Nusrat J Epsi, Simon D Pollett, et al.
Science Translational Medicine|April 5, 2022
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodiesSabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
Plos One|April 16, 2024
SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-upLiana R Andronescu, Stephanie A Richard, Ann I Scher, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine boosterSabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
Plos One|June 3, 2026
Correction: SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-upLiana R Andronescu, Stephanie A Richard, Ann I Scher, et al.
Open Forum Infectious Diseases|July 25, 2022
COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations With Infecting Genotype, Vaccine History, and Return to HealthStephanie A Richard, Nusrat J Epsi, David A Lindholm, et al.
Plos One|February 9, 2023
A machine learning approach identifies distinct early-symptom cluster phenotypes which correlate with hospitalization, failure to return to activities, and prolonged COVID-19 symptomsNusrat J Epsi, John H Powers, David A Lindholm, et al.
Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Open Forum Infectious Diseases|July 28, 2022
An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 InfectionAnn I Scher, Catherine M Berjohn, Celia Byrne, et al.
Open Forum Infectious Diseases|December 13, 2021
Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019Stephanie A Richard, Nusrat J Epsi, Simon Pollett, et al.
Scientific Reports|December 28, 2022
Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19Paul W Blair, Joost Brandsma, Josh Chenoweth, et al.
Open Forum Infectious Diseases|February 10, 2022
Anatomical Site, Viral Ribonucleic Acid Abundance, and Time of Sampling Correlate With Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 During InfectionF Julian Lantry, Nusrat J Epsi, Simon D Pollett, et al.
Science Translational Medicine|April 5, 2022
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodiesSabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
Plos One|April 16, 2024
SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-upLiana R Andronescu, Stephanie A Richard, Ann I Scher, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2022
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine boosterSabrina Lusvarghi, Simon D Pollett, Sabari Nath Neerukonda, et al.
Plos One|June 3, 2026
Correction: SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-upLiana R Andronescu, Stephanie A Richard, Ann I Scher, et al.
Open Forum Infectious Diseases|July 25, 2022
COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations With Infecting Genotype, Vaccine History, and Return to HealthStephanie A Richard, Nusrat J Epsi, David A Lindholm, et al.
Plos One|February 9, 2023
A machine learning approach identifies distinct early-symptom cluster phenotypes which correlate with hospitalization, failure to return to activities, and prolonged COVID-19 symptomsNusrat J Epsi, John H Powers, David A Lindholm, et al.
Pageof 17